Pharma Cinq, LLC
Records under this name other than the patents Pharma Cinq, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 40 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,175,295 | Antibodies and Methods for the Detection of Cell Death now held by PDL Biopharma, Inc. In force · High confidence | In force | High confidence | |
| US 12,758,570 | Uridine Triacetate Amorphous Formulation now held by Wellstat Therapeutics Corporation In force · High confidence | In force | High confidence | |
| US 7,906,675 | Compounds for the Treatment of Metabolic Disorders Term ended Term ended Oct 29, 2026 · High confidence | Term ended | Term ended Oct 29, 2026 | High confidence |
| US 7,767,200 | Cancer Treatment Using Viruses, Fluoropyrimidines and Camptothecins Term ended Term ended Jul 12, 2026 · High confidence | Term ended | Term ended Jul 12, 2026 | High confidence |
| US 7,914,979 | Stable and Filterable Enveloped Virus Formulations Term ended Term ended Nov 4, 2025 · High confidence | Term ended | Term ended Nov 4, 2025 | High confidence |
| US 9,844,574 | Cancer Treatment Using Viruses and Camptothecins Term ended Term ended Apr 26, 2025 · High confidence | Term ended | Term ended Apr 26, 2025 | High confidence |
| US 7,514,555 | Compounds for the Treatment of Metabolic Disorders Term ended Term ended Dec 5, 2024 · High confidence | Term ended | Term ended Dec 5, 2024 | High confidence |
| US 7,361,686 | Compounds for the Treatment of Metabolic Disorders Term ended Term ended Apr 20, 2024 · High confidence | Term ended | Term ended Apr 20, 2024 | High confidence |
| US 7,442,796 | Compounds for the Treatment of Metabolic Disorders Term ended Term ended Apr 20, 2024 · High confidence | Term ended | Term ended Apr 20, 2024 | High confidence |
| US 7,101,910 | Compounds for the Treatment of Metabolic Disorders Term ended Term ended Jul 24, 2023 · High confidence | Term ended | Term ended Jul 24, 2023 | High confidence |